Sabra Health Care REIT Hits New 52-Week High at $20.88

Sabra Health Care REIT, Inc. has reached a significant milestone by hitting a new 52-week high of USD 20.88 on February 26, 2026. This achievement underscores the company's strong performance in the realty sector, particularly as it has recorded a remarkable 48.26% increase over the past year, significantly outpacing the S&P 500's performance of 12.95%. With a market capitalization of USD 5,025 million, Sabra Health Care REIT, Inc. is classified as a small-cap company. The stock's price-to-earnings (P/E) ratio stands at 24.00, reflecting its valuation in the market. Additionally, the company boasts an impressive dividend yield of 552.13%, which may appeal to income-focused investors. The stock's performance metrics indicate a return on equity of 5.87% and a price-to-book ratio of 1.78. The 52-week low for Sabra Health Care REIT, Inc. was recorded at USD 15.75, highlighting the significant upward movement in its stock price. This milestone marks an important moment for the company as it continues to navigate the realty landscape.